Date | Title | Description | Source |
10.01.2022 | Dynavax Highlights 2022 Priorities and Announces Initiation ... | EMERYVILLE, Calif., Jan. 10, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a... | marketscre... |
28.12.2021 | COVID-19 Vaccine Developed by Biological E Using Dynavax's C... | EMERYVILLE, Calif., Dec. 28, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) a ... | marketscre... |
04.11.2021 | Dynavax Reports Third Quarter 2021 Financial Results | EMERYVILLE, Calif., Nov. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a ... | marketscre... |
27.10.2021 | Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity T... | TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-CO... | en.prnasia... |
21.10.2021 | Dynavax Technologies : Scott Myers Appointed to Dynavax Boar... | EMERYVILLE, Calif., Oct. 21, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a... | marketscre... |
18.10.2021 | Dynavax Technologies : COVID-19 Vaccine Developed by Valneva... | EMERYVILLE, Calif., Oct. 18, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a... | marketscre... |
04.10.2021 | Dynavax Technologies : and U.S. Department of Defense Announ... | EMERYVILLE, Calif., Oct. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a ... | marketscre... |
23.08.2021 | Medigen Vaccine Biologics Announces Launch of Its COVID-19 V... |
TAIPEI, Taiwan and EMERYVILLE, Calif., Aug. 23, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Cor... | prnewswire... |
23.08.2021 | Dynavax Technologies : Medigen Vaccine Biologics Announces L... | TAIPEI, Taiwan and EMERYVILLE, Calif., Aug. 23, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corpo... | marketscre... |
04.08.2021 | Dynavax Technologies : Announces Second Quarter 2021 Financi... | EMERYVILLE, Calif., Aug. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a ... | marketscre... |
04.08.2021 | Dynavax Announces Second Quarter 2021 Financial Results |
EMERYVILLE, Calif., Aug. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), ... | prnewswire... |
06.07.2021 | Dynavax and Biological E Announce Commercial Supply Agreemen... |
EMERYVILLE, Calif. and HYDERABAD, India, July 6, 2021 /PRNewswire/ -- Dynavax Technologies Corpora... | prnewswire... |
06.07.2021 | Dynavax Technologies : and Biological E Announce Commercial ... | EMERYVILLE, Calif. and HYDERABAD, India, July 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporati... | marketscre... |
30.06.2021 | Dynavax Technologies : Clover and Dynavax Announce Commercia... | CHENGDU, China, and EMERYVILLE, Calif., June 30, 2021 /PRNewswire/ -- Clover Biopharmaceuticals (Clo... | marketscre... |
30.06.2021 | Clover and Dynavax Announce Commercial Supply Agreement of D... |
Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's ... | prnewswire... |
30.06.2021 | Dynavax Technologies : Clover and Dynavax Announce Commercia... | Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's CO... | marketscre... |
30.06.2021 | Clover and Dynavax Announce Commercial Supply Agreement of D... | Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's CO... | en.prnasia... |
30.06.2021 | Clover and Dynavax Announce Commercial Supply Agreement of D... |
CHENGDU, China, and EMERYVILLE, Calif., June 30, 2021 /PRNewswire/ -- Clover Biopharmaceuticals (C... | prnewswire... |
27.05.2021 | DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Technologies : Ann... | EMERYVILLE, Calif., May 27, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a ... | marketscre... |
27.05.2021 | Dynavax Announces Agreement with Bavarian Nordic for Commerc... |
EMERYVILLE, Calif., May 27, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), ... | prnewswire... |
11.05.2021 | Dynavax Announces Pricing of $200 Million Convertible Senior... |
EMERYVILLE, Calif., May 11, 2021 /PRNewswire/ -- Dynavax Technologies Corporation ("Dynavax&q... | prnewswire... |
11.05.2021 | DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Technologies : Ann... | EMERYVILLE, Calif., May 11, 2021 /PRNewswire/ -- Dynavax Technologies Corporation ("Dynavax&quo... | marketscre... |
06.05.2021 | DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Technologies : Ann... | EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a b... | marketscre... |
06.05.2021 | Dynavax Announces First Quarter 2021 Financial Results |
EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a... | prnewswire... |
24.03.2021 | Clover Biopharmaceuticals and Dynavax Announce First Partici... |
Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA across Lati... | prnewswire... |
24.03.2021 | Clover Biopharmaceuticals and Dynavax Announce First Partici... |
CHENGDU, China and EMERYVILLE, Calif., March 24, 2021 /PRNewswire/ -- Clover Biopharmaceuticals (C... | prnewswire... |
24.03.2021 | Clover Biopharmaceuticals : and Dynavax Announce First Parti... | Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA across Latin ... | marketscre... |
25.02.2021 | Dynavax Announces Fourth Quarter and Full Year 2020 Financia... |
EMERYVILLE, Calif., Feb. 25, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX),... | prnewswire... |
23.02.2021 | Dynavax Technologies : China's Clover raises $230 mln, plans... | BEIJING, Feb 23 (Reuters) - China's Clover Biopharmaceuticals, a developer of coronavirus vaccines, ... | marketscre... |
23.02.2021 | DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Technologies : Chi... | BEIJING, Feb 23 (Reuters) - China's Clover Biopharmaceuticals, a developer of coronavirus vaccines, ... | marketscre... |
19.02.2021 | Dynavax Announces European Commission Marketing Authorizatio... |
EMERYVILLE, Calif., Feb. 19, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX),... | prnewswire... |
01.02.2021 | Clover Biopharmaceuticals Announces Publication of Phase 1 C... |
Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability pro... | prnewswire... |
01.02.2021 | Clover and Dynavax Announce Planned Global Phase 2/3 Efficac... | Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 va... | marketscre... |
01.02.2021 | Dynavax Announces Exercise of Option to Reserve Additional C... |
EMERYVILLE, Calif., Feb. 1, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), ... | prnewswire... |
01.02.2021 | Clover Biopharmaceuticals : Announces Publication of Phase 1... | Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profi... | marketscre... |
01.02.2021 | Clover and Dynavax Announce Planned Global Phase 2/3 Efficac... |
Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 ... | prnewswire... |
01.02.2021 | Clover and Dynavax Announce Planned Global Phase 2/3 Efficac... |
EMERYVILLE, Calif. and CHENGDU, China, Feb. 1, 2021 /PRNewswire/ -- Clover Biopharmaceuticals (Clo... | prnewswire... |
20.01.2021 | Dynavax Appoints Kelly MacDonald as Chief Financial Officer |
EMERYVILLE, Calif., Jan. 20, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX),... | prnewswire... |
07.01.2021 | Dynavax Announces Final Immunogenicity and Interim Safety Re... |
EMERYVILLE, Calif., Jan. 7, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), ... | prnewswire... |
05.11.2020 | Dynavax Announces Third Quarter 2020 Financial Results |
EMERYVILLE, Calif., Nov. 5, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), ... | prnewswire... |
13.10.2020 | Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 ... |
TAPEI, Taiwan and EMERYVILLE, Calif., Oct. 13, 2020 /PRNewswire/ -- Medigen Vaccine Biologics Corp... | prnewswire... |
03.08.2020 | TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Pr... | Purchase agreement for up to $250 million in milestone payments plus royalties on future net sales
... | tullisfund... |
19.06.2020 | DYNAVAX TECHNOLOGIES CORPORATION
Dynavax Announces First Pa... | Preclinical results demonstrated the ability of CpG 1018-adjuvanted SCB-2019 to elicit neutralizing ... | marketscre... |
04.08.2017 | Is the new Dynavax hepatitis vaccine safe? I couldn’t tell —... | The Food and Drug Administration recently had a very important question about a new hepatitis vaccin... | statnews.c... |
24.10.2011 | GSK expands Dynavax partnership, aims for new lupus, arthrit... | Dynavax is developing inhibitors of “toll-like receptors,” or TLRs, which are key receptors of the i... | medcitynew... |
- | GSK expands Dynavax partnership, aims for new lupus, arthrit... | GlaxoSmithKline (NYSE:GSK) has added a new target to its strategic partnership with California biote... | medcitynew... |